IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pianka, P.
Right arrow Articles by Geyer, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pianka, P.
Right arrow Articles by Geyer, O.
(Investigative Ophthalmology and Visual Science. 2000;41:880-886.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Nonadrenergic, Noncholinergic Relaxation of Bovine Iris Sphincter: Role of Endogenous Nitric Oxide

Pazit Pianka1, Yoram Oron2, Moshe Lazar1 and Orna Geyer1

1 From the Department of Ophthalmology, The Tel Aviv Sourasky Medical Center; and the 2 Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, Israel.


   Abstract
Top
 Abstract
Introduction
 Materials and Methods
 Results
 Discussion
 References
 
PURPOSE. To investigate the role of endogenously generated nitric oxide (NO) in the relaxation of bovine iris sphincter.

METHODS. Isolated bovine sphincters were mounted on an isometric tension apparatus. Contraction–relaxation response was elicited by electrical field stimulation (ES; 12 Hz, 50-msec duration, 70–80 V). Relaxation was arbitrarily defined as maximal decrease of tension below prestimulation baseline after cessation of ES. We also determined the tissue levels of cyclic guanosine monophosphate (cGMP) by radioimmunoassay.

RESULTS. ES produced a biphasic response: contraction followed by relaxation. After cessation of ES, the muscle relaxed to below the initial baseline tension. Tetrodotoxin (TTX) abolished most of the contraction and all the relaxation response. Atropine blocked most of the contraction component, leaving the relaxation component unchanged. Prazosin and bupranolol ({alpha}1-adrenergic and ß-adrenergic antagonists, respectively) also did not affect the relaxation component of the response. Neither substance P nor its antagonist (N-acetyl-L-tryptophane 3,5-bis (trifluoromethyl)-benzyl ester; ATTB) inhibited or mimicked the response. The nitric oxide synthase (NOS) inhibitors N{omega}-nitro-L-arginine methyl ester (L-NAME), N{omega}-nitro-L-arginine (L-NNA), and aminoguanidine dose-dependently inhibited the relaxation response by 50% to 70%. The free radical scavenger 2-(4-carboxyphenyl)- 4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (carboxy-PTIO) and the guanylyl cyclase inhibitor methylene blue also abrogated 70% and 45% of the relaxation response, respectively. ES caused an increase in muscle cGMP from 2.3 ± 0.3 to 3.9 ± 0.5 picomoles per muscle. L-NNA or L-NAME significantly decreased the tissue cGMP content (to 1.2 ± 0.1 picomoles per muscle) and prevented the increase caused by ES.

CONCLUSIONS. The relaxation component of the iris sphincter response to ES is a distinct nonadrenergic, noncholinergic, ES-induced event. Most of the relaxation is mediated by the endogenously generated NO-guanylyl cyclase-cGMP cascade.


   Introduction
Top
 Abstract
 Introduction
Materials and Methods
 Results
 Discussion
 References
 
Nitric oxide (NO) is an important mediator of smooth muscle relaxation, particularly of the vascular smooth muscle.1 2 3 4 5 6 7 It has been found to mediate nonadrenergic, noncholinergic (NANC) relaxation of the respiratory,8 intestinal,9 10 11 and genitourinary12 13 smooth muscles. Despite the demonstration of nitric oxide synthase (NOS) in ocular tissues,14 15 16 17 18 19 20 21 22 23 24 25 the role of endogenously produced NO in ocular physiology and pathology is still unclear. Recently, several reports have demonstrated that ocular smooth muscles (trabecular meshwork, ciliary, and iris sphincter) respond to exogenous NO donors.26 27 28 29

In the present study, we investigated the role of endogenously produced NO. Using specific NOS or guanylyl cyclase inhibitors and monitoring the muscle cyclic guanosine monophosphate (cGMP) content, our data demonstrate that endogenous NO causes an increase in tissue cGMP and thereby mediates approximately 70% of the relaxation of bovine iris sphincter.


   Materials and Methods
Top
 Abstract
 Introduction
 Materials and Methods
Results
 Discussion
 References
 
Preparation of Bovine Iris Sphincters
Freshly enucleated bovine eyes were kept on ice and dissected immediately before each experiment. The entire sphincter was dissected as described elsewhere.26 The circular muscle preparation was mounted on an isometric tension apparatus in 15 ml Krebs–Ringer bicarbonate physiological salt solution continuously aerated with an O2-CO2 (95:5) gas mixture at 31°C.

Electrical Field Stimulation
After a 90- to 180-minute initial equilibration period with frequent solution changes, the tension of the preparation, measured with a force transducer (model FT03C; Grass Instrument, Quincy, MA) was adjusted to 0.5 to 1.0 g and maintained at this level throughout the experiment. Electrical stimulation (ES) was applied through two platinum wires parallel to the preparation. The tissue was stimulated for 24 seconds at 12 Hz, 80 V, and 50-msec pulse duration. These conditions have been found to produce optimal response (Fig. 1) . An additional stimulation was performed when the tension returned to baseline, but at no interval closer than minutes. Tension was measured with a polygraph amplifier-recorder (model 79C; Grass). Drugs were added directly to the organ bath from 100- to 1000-fold concentrated stock solutions.



View larger version (11K):
[in this window]
[in a new window]
  		Figure 1. ES-induced relaxation as a function of stimulus frequency or duration. Bovine sphincter was mounted on an isometric tension apparatus. Response was elicited by ES of 80 V, 50-msec pulse duration, and variable frequency (A) or at 12 Hz and variable pulse duration (B). Results are expressed as a percentage of maximal relaxation amplitude.

 
cGMP Determination
Entire iris sphincters were mounted on the isometric tension apparatus, and the desired experiments performed as described above and in the Results section. Immediately after the experiment, the muscle was quickly removed and frozen in liquid nitrogen. The frozen tissue was homogenized (Ultra-Turrax, Janke-Kunkel AG, Staufen, Germany; at setting 8, 10 seconds) in 3 ml cold 6% trichloroacetic acid. The homogenate was centrifuged 15 minutes at 2000g at 4°C. The supernatant was extracted four times with five volumes of water-saturated ether. Residual ether was removed by vacuum. After acetylation, 50-µl samples were assayed in duplicate for cGMP content by radioimmunoassay (RIA), using a cGMP determination kit (Biotrak RPA 525; Amersham, Arlington Heights, IL). Because of the difficulty of protein determination in the highly pigmented tissue, results were presented as picomoles cGMP per entire muscle.

Materials
N{omega}-nitro-L-arginine, L-NNA, N{omega}-nitro-L-arginine methyl ester (L-NAME), L-arginine, atropine methylnitrate, aminoguanidine, carbamylcholine, methylene blue, substance P, N-acetyl-L-tryptophane 3,5-bis (trifluoromethyl)-benzyl ester (ATTB), and prazosin were purchased from Sigma (St. Louis, MO). 2-(4-Carboxyphenyl)- 4,4,5,5-tetramethyl-imidazoline-1-oxyl-3-oxide (carboxy-PTIO) was produced by Calbiochem (La Jolla, CA). Bupranolol was a gift of Schwartz Pharma, Monheim, Germany. Tetrodotoxin (TTX) was purchased from Alomone Laboratories (Jerusalem, Israel). All other chemicals were of analytical grade. The composition of the Krebs–Ringer bicarbonate solution was (in mM): 118 NaCl, 4.7 KCl, 1.2 MgCl2, 2.5 CaCl2, 25 NaHCO3, 1.2 KH2PO4, and 11 glucose (pH 7.4).

Statistics
All experiments were repeated at least four times on sphincters obtained from different animals. Results are presented as mean ± SE. Student’s t-test was used to evaluate statistical significance at P < 0.05. For calculation of IC50 values, the normalized data (expressed as a percentage of maximal relaxation) were fitted to Michaelis–Menten kinetics using the GraFit program (Erithacus Software Ltd, Staines, UK).


   Results
Top
 Abstract
 Introduction
 Materials and Methods
 Results
Discussion
 References
 
ES resulted in a complex contractile response of the iris sphincter muscle. The response consisted of a rapid contraction followed by a variable phase. In some preparations the tonus of the muscle was either maintained throughout the ES period or decreased slightly. In many preparations, however, the contraction component was followed by a relaxation component of variable rate. After cessation of ES there was a rapid relaxation, which usually brought the muscle to a tension below the initial baseline. The magnitude of the decrease in muscle tension below that of the prestimulation baseline was arbitrarily defined by us as a measure of the relaxation component of the response. Typical recordings are shown in Figure 2A . For sphincters from the same batch analyzed on the same day, the relaxation response was reproducible. For example, analysis of nine sphincters yielded a mean relaxation value of 0.20 ± 0.02 g. In a minority of preparations (<10%), the tension returned to the baseline value after the cessation of ES. These preparations were not included in the study, because they had no distinct relaxation component. These results suggest that the relaxation component of the response resulted from the action of a neurotransmitter released by ES. Moreover, it appears to be a distinct phenomenon and not an absence of contraction.



View larger version (7K):
[in this window]
[in a new window]
  		Figure 2. Representative contraction–relaxation response. (A) Sphincter muscle mounted on an isometric tension apparatus was stimulated for 24 seconds at 80 V, 12 Hz, and 50-msec pulse duration (horizontal bar). (B) Stimulation of the same muscle, 10 minutes after the addition of 0.3 µM atropine.

 
To verify these hypotheses, we performed two experiments. We blocked most of the contraction component with 0.3 µM atropine, a muscarinic antagonist. Atropine inhibited the contraction component of the response by more than 80%, but the relaxation component of the response was unaffected (Fig. 2B) . We also subjected sphincters to ES in the presence of TTX, a blocker of fast sodium channels. TTX prevents depolarization of axons and thus blocks release of neurotransmitters. TTX at 0.4 µM blocked the relaxation component of the response and almost completely abolished the contractile component within 1 minute of its addition. Prolonged washout (60 minutes) of TTX resulted in a partial recovery of the original response (Fig. 3) .



View larger version (8K):
[in this window]
[in a new window]
  		Figure 3. The effect of TTX on ES-induced response. A contraction–relaxation response was elicited in an isolated bovine sphincter as described in Figure 2 . After three consecutive responses, 0.4 µM TTX was added and responses elicited by periodic stimulation. When maximal effect of TTX was observed, the tissue was repeatedly washed and subjected to a further series of stimulations. (A) Control response before the addition of TTX; (B) response obtained 1 minute after the addition of TTX; (C) partial recovery of the response obtained 60 minutes after removal of TTX and repeated washing. Similar results were obtained in three additional experiments.

 
Our results with atropine suggested that the generation of NO is not dependent on the stimulation of muscarinic receptors. We have also studied the possible involvement of the {alpha}1- and ß-adrenergic receptors. Because our previous studies30 showed that there is an involvement of ß3-adrenergic receptors in the relaxation of bovine iris sphincters, we used high-concentration (1 µM) bupranolol, which inhibits all ß-adrenergic receptor subtypes.31 Neither atropine, prazosin, or bupranolol affected the relaxation component of the response. Moreover, the proportion of the response that could be inhibited by 0.1 mM L-NAME did not change (Fig. 4) . We concluded, therefore, that the relaxation component reflects release of NANC transmitter(s).



View larger version (26K):
[in this window]
[in a new window]
  		Figure 4. The effects of sympathetic and parasympathetic antagonists on relaxation. Sphincters were treated as described in the Methods section and in Figure 2 . Drugs were added at least 10 minutes before ES. The results are presented as a percentage of control relaxation (without drugs). Each point represents the mean ± SE of 4 to 12 independent experiments. The concentrations of the drugs were atropine (ATR) 0.3 µM, prazosin (PRZ) 0.1 µM, and bupranolol (BUP) 1.0 µM.

 
It has been reported that substance P elicits contractile responses in bovine sphincter.32 We tried, therefore, to test whether substance P receptors participate in the relaxation response. Substance P alone had a small contractile effect (24% ± 5% of that produced by ES), even at concentrations as high as 1 µM (not shown). Substance P (0.2–1.0 µM) potentiated the ES-induced relaxation response by 14% ± 7%. ATTB, an antagonist of neurokinin-1 receptors, alone had no effect on sphincter tension (not shown). At very high concentration (1 µM), it potentiated both contraction and relaxation by approximately 40% to 50%. This potentiation, however, was observed with the vehicle alone (1% dimethyl sulfoxide). These results indicate that substance P is not the neurotransmitter responsible for ES-induced relaxation.

To investigate the possible contribution of the endogenously generated NO to the relaxation component of the response, we used the specific NOS inhibitors L-NAME, L-NNA, and aminoguanidine. L-NNA (0.1 mM) inhibited relaxation by 65% ± 11% (n = 9, P < 0.02, Fig. 6 ). L-NAME dose-dependently inhibited the relaxation component of the response with an IC50 of 60 nM and maximal effect (68% inhibition) at more than 10 µM. Similar results were obtained with the inhibitor of inducible NOS, aminoguanidine. The IC50 was, however, 11.5 µM, suggesting that the enzyme participating in the relaxation response was constitutive NOS. These results are shown in Figure 5 .



View larger version (13K):
[in this window]
[in a new window]
  		Figure 6. Inhibition of relaxation by various drugs. The experiments were conducted essentially as described in the Methods section and in Figure 1 . After three to four control contraction–relaxation responseswere obtained, drugs were added at the following concentrations: aminoguanidine (AG) and L-NAME 10 µM, L-NNA 100 µM; methylene blue (MB) 200 µM, and carboxy-PTIO (c-PTIO) 500 µM. After at least 10 minutes, additional ES was applied. Results are presented as inhibition of control relaxation (before the addition of any drug). Each column represents the mean ± SE of four to nine experiments.

 


View larger version (17K):
[in this window]
[in a new window]
  		Figure 5. Inhibition of relaxation: Dose response to NOS inhibitors. Control relaxation was determined on each sphincter by obtaining three similar consecutive contraction–relaxation complexes. The ES was thereafter repeated at 3-minute intervals in the presence of increasing doses of the drugs, starting 10 minutes after the drugs’ addition. Relaxation was calculated as a percentage of the control response (i.e., before the addition of the drugs). Each point represents the mean ± SE of five to six or three to four independent assays for L-NAME and aminoguanidine, respectively.

 
NOS inhibitors often increased the slope of the contraction component, partially or fully prevented the decrease in tension during the ES period, and decreased the slope of the relaxation on cessation of ES. These results (not shown) suggest that relaxation proceeds independently of and in parallel with the contraction component from the onset of ES.

To further verify the involvement of endogenously generated NO in the relaxation response, we used the free radical scavenger carboxy-PTIO. In four experiments, 0.5 mM carboxy-PTIO inhibited the relaxation component by 70% ± 7% (P < 0.02). Similarly, the guanylyl cyclase inhibitor methylene blue inhibited the relaxation response by 45% ± 3% (n = 5, P < 0.02). These results are shown in Figure 6 . Therefore, pharmacologic investigation strongly suggests that at least 70% of the relaxation component of the response to ES is mediated by endogenously generated NO.

To complement our study, we have attempted to potentiate the relaxation component of the response by adding the NOS substrate L-arginine. Although we observed variable potentiation of the relaxation in some experiments, usually L-arginine had no effect on the response. This suggests that endogenous arginine concentration is usually sufficient to support maximal relaxation. L-Arginine, at 1.0 mM or higher, was inhibitory to both the contraction and the relaxation components of the response, suggesting nonspecific effects.

To confirm the hypothesis that ES causes an increase of endogenously generated NO and produces relaxation through the activation of guanylyl cyclase, we assayed the content of iris sphincter cGMP under a variety of conditions. ES for 24 seconds produced an increase in the cGMP content (from 2.3 ± 0.3 to 3.9 ± 0.5 picomoles per sphincter; n = 8 and 7, respectively; P < 0.02). Incubation of the sphincters with 10 µM L-NNA or L-NAME produced a modest but significant decrease in cGMP content (to 1.2 ± 0.1 picomoles per sphincter; n = 5; P < 0.02), which was not affected by ES (1.5 ± 0.1 picomoles per sphincter; n = 7; not significant relative to L-NNA or L-NAME alone). These results (Fig. 7) are consistent with ES-induced increase in tissue NO, which activated guanylyl cyclase. The increased cGMP caused the relaxation of the iris sphincter muscle.



View larger version (11K):
[in this window]
[in a new window]
  		Figure 7. The effects of ES and drugs on sphincter cGMP content. Sphincters were mounted on the isometric tension apparatus and stimulated as described in the Methods section and Figure 1 . The tissue was removed from the bath at the point of maximal relaxation and rapidly frozen in liquid nitrogen. cGMP was assayed as described in the Methods section. Drugs, when present, were added at least 10 minutes before the tissue was frozen. Each column represents the mean ± SE of seven to eight determinations in different sphincters. Because the effects of NOS inhibitors (either L-NNA or L-NAME, 10 µM) were similar, the results were pooled. C, control (without ES); INH, NOS inhibitors (either L-NNA or L-NAME, 10 µM).

 

   Discussion
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
References
 
Several studies have documented existence of NOS or reduced nicotinamide adenine dinucleotide phosphate (NADPH) diaphorase in ocular tissues, among which are the conjunctiva,33 iris vasculature,34 iris sphincter,26 33 35 ciliary processes and ciliary muscle,36 37 trabecular meshwork,36 37 choroid,36 and retina.33 36 38 39 40 In the present report, we suggest a physiological function of this enzyme in the normal bovine eye. Our results demonstrate a distinct mechanism for the relaxation of the iris sphincter. Similar to the mechanisms operating in the vascular smooth muscle, relaxation is an independent process rather than simply a cessation of contraction. Endogenously generated NO appears to serve as the mediator of relaxation according to a number of pharmacologic criteria. Relaxation due to exogenously administered NO donors has been shown previously.10 26 27 28 41 42 43 Here, we demonstrated that inhibitors of NOS abolished most of the relaxation response. The same effect was observed when the effector enzyme guanylyl cyclase was inhibited by methylene blue and when NO was eliminated by the free radical scavenger carboxy-PTIO. The specific inhibitors of constitutive NOS were much more potent than aminoguanidine, an inhibitor of the inducible enzyme.44 Therefore, the relaxation of iris sphincter appears to be largely mediated by NO synthesized by constitutive NOS.

The accepted pathway of NO signal transduction includes the activation of guanylyl cyclase and an increase in cellular cGMP. The results of cGMP determination are consistent with this mechanism. ES increased sphincter cGMP content almost twofold, whereas L-NNA or L-NAME decreased the basal level to 50% of the control values. Moreover, NOS inhibitors prevented the increase in cGMP due to ES.

The basal levels of cGMP were determined per intact sphincter muscle. The wet weight of bovine sphincter averages approximately 0.2 g, with a conservative estimate of protein content of approximately 20 mg per muscle. These rough assumptions yield cGMP content of the resting tissue of approximately 0.1 picomole per milligram protein. This was similar to the values found for the human lower esophageal sphincter43 and the rat ileum11 and somewhat lower than that reported for rabbit urethra strips.13 In other tissues, much higher values were reported. In pig gastric fundus,10 cat adrenals,42 and rabbit iris sphincter26 27 the values vary between 0.7 and 3.0 picomoles per milligram. In the few reports of the effect of ES on cGMP content (range between 50% and 150% in unstimulated control samples10 11 12 41 43 ), the increases brought about by ES were comparable to those found here. Moro et al.42 alone have reported up to a 15-fold increase in cGMP content after ES in cat adrenals. The tissue cGMP can be markedly elevated by exogenous NO donors (e.g., sodium nitroprusside) in a variety of smooth muscles, which explains their potency as relaxants.26 29 41 42 43 However, our results and those of other laboratories10 11 12 41 43 indicate that a twofold increase is sufficient to obtain the maximal physiological relaxation.

The extent of the participation of NO in the relaxation process was estimated conservatively as approximately 70%. We based this estimate on the maximal inhibition of relaxation by L-NAME, L-NNA, aminoguanidine, or carboxy-PTIO. This may be interpreted in terms of two mechanisms of relaxation: one that is NO-mediated and an additional unknown mechanism that mediates the remaining 30% of the response.

Independent of these considerations, it is obvious that a NANC pathway activates the relaxation of the bovine iris sphincter. Despite the existence of neurokinin-1 receptors and a demonstration that substance P may elicit a contractile response in the isolated sphincter,32 our data rule out this transmitter as a cause of sphincter relaxation. Relaxation may be due to a direct nitrergic innervation (as is demonstrated in Reference 45) or to a release of another transmitter that, in turn, activates the enzyme in the sphincter muscle. Our data demonstrate the feasibility of sphincter relaxation through the nitrergic pathway. Further experiments in vivo are required to assess the importance of this pathway in normal physiology.


   Footnotes
 
Supported by a Binational Science Foundation grant (YO) and the Foglanst Grant for Eye Research (OG).

Submitted for publication November 18, 1998; revised April 7, 1999; accepted May 4, 1999.

Commercial relationships policy: N.

Corresponding author: Orna Geyer, Department of Physiology and Pharmacology, Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv 69978, Israel. drgo{at}netvision.net.il


   References
Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Moncada, S, Palmer, RMJ, Higgs, EA (1991) Nitric oxide: physiology, pathophysiology and pharmacology Phamacol Rev 43,l09-l142
  2. Palmer, RMJ, Ferrige, AG, Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor Nature 327,524-526[Medline][Order article via Infotrieve]
  3. Bredt, DS, Snyder, SH (1992) Nitric oxide, a novel neuronal messenger Neuron 8,3-11[Medline][Order article via Infotrieve]
  4. Bolotina, VM, Najibi, S, Palacino, JJ, Pagano, PJ, Cohen, RA (1994) Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle Nature 368,850-853[Medline][Order article via Infotrieve]
  5. Gillespie, JS, Sheng, H. (1988) Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor and nitric oxide on vascular and non-vascular smooth muscle Br J Pharmacol 88,1151-1156
  6. Ignaro, LJ (1991) Signal transduction mechanisms involving nitric oxide Biochem Pharmacol 41,485-490[Medline][Order article via Infotrieve]
  7. Moncada, S, Higgs, A. (1993) The L-arginine-nitric oxide pathway N Engl J Med 329,2002-2012[Free Full Text]
  8. Tucker, JF, Brave, SR, Charalambous, L, Hobbs, AJ, Gibson, A. (1990) L-NG-nitro arginine inhibits non-adrenergic, non-cholinergic relaxations of guinea-pig isolatetracheal smooth muscle Br J Pharmacol 100,663-664[Medline][Order article via Infotrieve]
  9. Toda, N, Minami, Y, Okamura, T. (1990) Role of nitric oxide in non-adrenergic non-cholinergic nerve-mediated relaxation in dog duodenal longitudinal muscle strips Jpn J Pharmacol 53,281-284[Medline][Order article via Infotrieve]
  10. Lefebvre, RA, Smits, GJ, Timmermans, JP (1995) Study of NO and VIP as non-adrenergic, non-cholinergic neurotransmitters in the pig gastric fundus Br J Pharmacol l16,2017-2026
  11. Smits, GJ, Lefebvre, RA (1996) Influence of age on cholinergic and inhibitory nonadrenergic noncholinergic responses in the rat ileum Eur J Pharmacol 303,79-86[Medline][Order article via Infotrieve]
  12. Dokita, S, Morgan, WR, Wheeler, MA, Yoshida, M, Latifpour, J, Weiss, RM (1991) N{omega}-nitro-L-arginine inhibits non-adrenergic, non-cholinergic relaxation in rabbit urethral smooth muscle Life Sci 48,2429-2436[Medline][Order article via Infotrieve]
  13. Dokita, S, Smith, SD, Nishimoto, T, Wheeler, MA, Weiss, RM (1994) Involvement of nitric oxide and cyclic GMP in rabbit urethral relaxation Eur J Pharmacol 266,269-275[Medline][Order article via Infotrieve]
  14. Becquet, F, Courtois, Y, Goureau, O. (1997) Nitric oxide in the eye: multifaceted roles and diverse outcomes Surv Ophthalmol 42,71-82[Medline][Order article via Infotrieve]
  15. Anderson, PJ, Wang, J, Epstein, D. (1980) Metabolism of calf trabecular (reticular) meshwork Invest Ophthalmol Vis Sci 19,13-20[Abstract/Free Full Text]
  16. Becquet, F, Yapo, A, Courtois, Y, Gouzou, O (1996) NO synthase expression in RCS rat retina [ARVO Abstract] Invest Ophthalmol Vis Sci 37(3),S627Abstract nr 2897
  17. Behar–Cohen, FF, Goureau, O, D’Hermies, F, Courtois, Y. (1996) Decreased intraocular pressure induced by nitric oxide donors is correlated to nitric oxide production in the rabbit eye Invest Ophthalmol Vis Sci 37,1711-1715[Abstract/Free Full Text]
  18. Deussen, A, Sonntag, M, Vogel, R. (1993) L-arginine-derived nitric oxide: a major determinant of uveal blood flow Exp Eye Res 57,129-134[Medline][Order article via Infotrieve]
  19. Fisher, LJ, Guerin, CJ, Schiffman, RM (1996) Nitric oxide synthase is located in the epithelia of the ciliary processes [ARVO Abstract] Invest Ophthalmol Vis Sci 37(3),S838Abstract nr 3872
  20. Geyer, O, Almog, J, Lupo–Meiri, M, Lazar, M, Oron, Y. (1995) Nitric oxide synthase inhibitors protect rat retina against ischemic injury FEBS Lett 374,399-402[Medline][Order article via Infotrieve]
  21. Koch, KW, Lambrecht, HG, Haberecht, M, Redburn, D, Schmidt, HH (1994) Functional coupling of a Ca2+/calmodulin-dependent nitric oxide synthase and a soluble guanylyl cyclase in vertebrate photoreceptor cells EMBO J 13,3312-3320[Medline][Order article via Infotrieve]
  22. Mann, RM, Riva, CE, Stone, RA, Barnes, GE, Granstoun, SD (1995) Nitric oxide and choroidal bloodflow regulation Invest Ophthalmol Vis Sci 36,925-930[Abstract/Free Full Text]
  23. Ostwald, P, Goldstein, IM, Pachnanda, A, Roth, S. (1995) Effect of nitric oxide synthase inhibition on blood flow after retinal ischemia in cats Invest Ophthalmol Vis Sci 36,2396-2403[Abstract/Free Full Text]
  24. Perez, MRT, Larsson, B, Alm, P, Ehinger, B. (1995) Localization of neuronal nitric oxide synthase immunoreactivity in rat and rabbit retinas Exp Brain Res 104,207-217[Medline][Order article via Infotrieve]
  25. Venturini, CM, Knowles, RG, Palmer, RM, Moncada, S. (1991) Synthesis of nitric acid in the bovine retina Biochem Biophys Res Commun 180,920-925[Medline][Order article via Infotrieve]
  26. Chuman, T, Chuman, H, Nao-i, N, Sawada, A, Yamamoto, R, Wada, A. (1996) Nitric oxide-sensitive and -insensitive contractions of the isolated rabbit iris sphincter muscle Invest Ophthalmol Vis Sci 37,1437-1443[Abstract/Free Full Text]
  27. Chuman, H, Chuman, T, Nao-i, N, et al (1997) Different responsiveness to nitric oxide-cyclic guanosine monophosphate pathway in cholinergic and tachykinergic contractions of the rabbit iris sphincter muscle Invest Ophthalmol Vis Sci 38,1719-1725[Abstract/Free Full Text]
  28. Wiederholt, M, Sturum, A, Lepple–Wienhues, A. (1994) Relaxation of trabecular meshwork and ciliary muscle by release of nitric oxide Invest Ophthalmol Vis Sci 35,2515-2520[Abstract/Free Full Text]
  29. Goh, Y, Hotehama, Y, Mishima, HK (1995) Characterization of ciliary muscle relaxation induced by various agents in cats Invest Ophthalmol Vis Sci 36,1188-1196[Abstract/Free Full Text]
  30. Geyer, O, Bar-Ilan, A, Nachman, R, Lazar, M, Oron, Y. (1998) ß3-Adrenergic relaxation of bovine iris sphincter FEBS Lett 429,356-358[Medline][Order article via Infotrieve]
  31. Blin, N, Camoin, L, Maigret, B, Strosberg, AD (1993) Structural and conformational features determining selective signal transduction in the beta 3-adrenergic receptor Mol Pharmacol 44,1094-1104[Abstract]
  32. Tachado, SD, Akhtar, RA, Yousufzai, SY, Abdel–Latif, AA (1991) Species differences in the effects of substance P on inositol trisphosphate accumulation and cyclic AMP formation, and on contraction in isolated iris sphincter of the mammalian eye: differences in receptor density Exp Eye Res 53,729-739[Medline][Order article via Infotrieve]
  33. Osborne, NN, Barnett, NL, Herrera, AJ (1993) NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye Brain Res 610,194-198[Medline][Order article via Infotrieve]
  34. McMenamin, PG, Crewe, JM (1997) Cellular localisation and dynamics of nitric oxide synthase expression in the rat anterior segment during endotoxin-induced uveitis Exp Eye Res 65,157-164[Medline][Order article via Infotrieve]
  35. Haufschild, T, Nava, E, Meyer, P, Flammer, J, Luscher, TF, Haefliger, IO (1996) Spontaneous calcium-independent nitric oxide synthase activity in porcine ciliary processes Biochem Biophys Res Commun 222,786-789[Medline][Order article via Infotrieve]
  36. Geyer, O, Podos, SM, Mittag, T. (1997) Nitric oxide synthase activity in tissues of the bovine eye Graefes Arch Clin Exp Ophthalmol 235,786-793[Medline][Order article via Infotrieve]
  37. Nathanson, JA, McKee, M. (1995) Identification of extensive system of nitric oxide-producing cell in the ciliary muscle and outflow pathway of the human eye Invest Ophthalmol Vis Sci 36,1765-1773[Abstract/Free Full Text]
  38. Dawson, TM, Bredt, DS, Fotuhi, M, Hwang, PM, Snyder, SH (1994) Nitric oxide synthetase and neuronal NADPH-diaphorase are identical in brain and peripheral tissues Proc Natl Acad Sci USA 88,7797-7801[Abstract/Free Full Text]
  39. Yoshida, A, Pozdnyakov, N, Dang, L, Orselli, SM, Reddy, VN, Sitaramayya, A (1995) Nitric oxide synthesis in retinal photoreceptor cells Vis Neurosci 12,493-500[Medline][Order article via Infotrieve]
  40. Yamamoto, R, Bredt, DS, Snyder, SH, Stone, RA (1993) The localization of nitric oxide synthase in the rat eye and related cranial ganglia Neuroscience 54,189-200[Medline][Order article via Infotrieve]
  41. Persson, K, Andersson, KE (1994) Non-adrenergic, non-cholinergic relaxation and levels of cyclic nucleotides in rabbit lower urinary tract Eur J Pharmacol 268,159-167[Medline][Order article via Infotrieve]
  42. Moro, MA, Michelena, P, Sanchez–Garcia, P, Palmer, R, Moncada, S, Garcia, AG (1993) Activation of adrenal medullary L-arginine: nitric oxide pathway by stimuli which induce the release of catecholamines Eur J Pharmacol 246,213-218[Medline][Order article via Infotrieve]
  43. Barnette, MS, Barone, FC, Fowler, PJ, Grous, M, Price, WJ, Ormsbee, HS (1991) Human lower oesophageal sphincter relaxation is associated with raised cyclic nucleotide content Gut 32,4-9[Abstract/Free Full Text]
  44. Forstermann, U, Gath, I, Schwarz, P, Closs, EI, Kleinert, H. (1995) Isoforms of nitric oxide synthase: properties, cellular distribution and expressional control Biochem Pharmacol 50,1321-1332[Medline][Order article via Infotrieve]
  45. Weincke, AK, Nilsson, H, Nielsen, PJ, Nyborg, NC (1994) Nonadrenergic noncholinergic vasodilation in bovine ciliary artery involves CGRP and neurogenic nitric oxide Invest Ophthalmol Vis Sci 35,3268-3277[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
T. A. White, T. F. Walseth, and M. S. Kannan
Nitric oxide inhibits ADP-ribosyl cyclase through a cGMP-independent pathway in airway smooth muscle
Am J Physiol Lung Cell Mol Physiol, November 1, 2002; 283(5): L1065 - L1071.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pianka, P.
Right arrow Articles by Geyer, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pianka, P.
Right arrow Articles by Geyer, O.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS